Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D supplementation with intravitreal bevacizumab for diabetic macular edema
IRCT20240411061466N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Jun 2024
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bevacizumab and vitamin d in diabetic macular edema (DME) and diabetic retinopathy (DR), sponsored by Kerman University of Medical Sciences. Started Jun 2024; status: completed.
02
Drugs
bevacizumabvitamin d
03
Conditions
diabetic macular edema (DME)diabetic retinopathy (DR)
Beyond the preview
Go deeper on IRCT20240411061466N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240411061466N1.